1. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria;Banwell;Lancet Neurol.,2023
2. Comparison of Relapse Rates and Treatment Failure Rates in Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD);Bilodeau;Mult. Scler.,2023
3. Treatment at onset predicts a longer time-to-relapse after index event in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD);Bilodeau;Neurology,2023
4. MOG consortium consensus: part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders;Bruijstens;Eur. J. Paediatr. Neurol.,2020
5. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder;Chen;Neurology,2020